Zhongyi Yuan

Zhongyi Yuan


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2021 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
CCChunsheng Cai
Chunsheng Cai
JYJia Yao
Jia Yao
LCLie Chen
Lie Chen
ZYZhongyi Yuan
Zhongyi Yuan
ZZZhi‐Guo Zhang
Zhi‐Guo Zhang
JSJinjun Shao
Jinjun Shao

30 September 2024 in Advanced Functional Materials
Verified
Journal Article
Closed access
KZKe Zhong
Ke Zhong
JDJiawei Deng
Jiawei Deng
RZRui Zeng
Rui Zeng
JXJie Xu
Jie Xu
ZYZhongyi Yuan
Zhongyi Yuan
FLFeng Liu
Feng Liu

15 September 2016 in The Journal of Physical Chemistry A
Verified
Journal Article
Closed access
XZXiaohong Zhao
Xiaohong Zhao
YXYushuai Xiong
Yushuai Xiong
JMJie Ma
Jie Ma
ZYZhongyi Yuan
Zhongyi Yuan

16 April 2019 in Organic Letters
Verified
Journal Article
Closed access
XHXiaoshuai Huang
Xiaoshuai Huang
MHMing Hu
Ming Hu
XZXiaohong Zhao
Xiaohong Zhao
CLChao Li
Chao Li
ZYZhongyi Yuan
Zhongyi Yuan
YCYiwang Chen
Yiwang Chen

10 May 2024 in Advanced Science
Verified
Journal Article
Open access
MXMengmeng Xiong
Mengmeng Xiong
YZYing Zhang
Ying Zhang
HZHuan Zhang
Huan Zhang
QSQiaoqiao Shao
Qiaoqiao Shao
QHQifan Hu
Qifan Hu
HWHao Wan
Hao Wan
Aggressive nature of colon cancer and current imprecise therapeutic scenarios simulate the development of precise and effective treatment strategies. To achieve this, a tumor environment‐activated photosensitized biomimetic nanoplatform (PEG2000‐SiNcTI‐Ph/CpG‐ZIF‐8@CM) is fabricated by encapsulating metal‐organic framework loaded with developed photosensitizer PEG2000‐SiNcTI‐Ph and immunoadjuvant CpG oligodeoxynucleotide within fusion cell membrane expressing programmed death protein 1 (PD‐1) and cluster of differentiation 47 (CD47). By stumbling across, systematic evaluation, and deciphering with quantum chemical calculations, a unique attribute of tumor environment (low pH plus high concentrations of adenosine 5′‐triphosphate (ATP))‐activated photodynamic effect sensitized by long‐wavelength photons is validated for PEG2000‐SiNcTI‐Ph/CpG‐ZIF‐8@CM, advancing the precision of cancer therapy. Moreover, PEG2000‐SiNcTI‐Ph/CpG‐ZIF‐8@CM evades immune surveillance to target CT26 colon tumors in mice mediated by CD47/signal regulatory proteins α (SIRPα) interaction and PD‐1/programmed death ligand 1 (PD‐L1) interaction, respectively. Tumor environment‐activated photodynamic therapy realized by PEG2000‐SiNcTI‐Ph/CpG‐ZIF‐8@CM induces immunogenic cell death (ICD) to elicit anti‐tumor immune response, which is empowered by enhanced dendritic cells (DC) uptake of CpG and PD‐L1 blockade contributed by the nanoplatform. The photodynamic immunotherapy efficiently combats primary and distant CT26 tumors, and additionally generates immune memory to inhibit tumor recurrence and metastasis. The nanoplatform developed here provides insights for the development of precise cancer therapeutic strategies.

6 March 2025 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
SXShuangshuang Xia
Shuangshuang Xia
JXJie Xu
Jie Xu
ZWZongtao Wang
Zongtao Wang
SLSeunglok Lee
Seunglok Lee
LWLei Wang
Lei Wang
ZYZhongyi Yuan
Zhongyi Yuan